SPONSOR
Craig van Horne, MD, PhD
Total Trials
2
Recruiting
2
Phases
Phase 1
Craig van Horne, MD, PhD is a clinical research sponsor with 2 registered studies on ClinicalTrials.gov, of which 2 are actively recruiting participants. Research covers conditions including Multiple System Atrophy, Parkinsons Disease, Parkinson's Disease.
The trial portfolio spans Phase 1 studies, reflecting a pipeline that may include early-stage safety evaluations, mid-stage efficacy assessments, and large-scale confirmatory trials. All studies listed here are sourced directly from ClinicalTrials.gov and updated daily.
Frequently Asked Questions — Craig van Horne, MD, PhD
How many clinical trials has Craig van Horne, MD, PhD sponsored?
ClinicalMetric currently tracks 2 clinical trials sponsored by Craig van Horne, MD, PhD, of which 2 are actively recruiting participants. These trials cover conditions including Multiple System Atrophy, Parkinsons Disease, Parkinson's Disease. Trial counts are updated daily from ClinicalTrials.gov and reflect currently registered studies.
What therapeutic areas does Craig van Horne, MD, PhD research focus on?
Craig van Horne, MD, PhD clinical trials span Multiple System Atrophy, Parkinsons Disease, Parkinson's Disease. The research pipeline includes Phase 1 trials, reflecting work from early-stage safety evaluation through large-scale efficacy studies.
How do I participate in a Craig van Horne, MD, PhD clinical trial?
To participate in a Craig van Horne, MD, PhD trial, review the active studies listed on this page, check each trial's specific eligibility criteria on ClinicalTrials.gov, and contact the trial site directly—not the sponsor's headquarters. Trial sites are academic medical centers, hospitals, or specialized research clinics. Your physician can facilitate a referral. ClinicalMetric lists all Craig van Horne, MD, PhD trials with current recruitment status updated daily.
Clinical Trials by Craig van Horne, MD, PhD
NCT06683365 Phase 1
Recruiting
Autologous suraL nervE Grafting to the Substantia nigrA in Patients With Synuclienopathies
Multiple System Atrophy
NCT06683378 Phase 1
Recruiting
A Study to Evaluate Feasibility, Safety, and Clinical Responses of Implanting Autologous Peripheral Nerve Tissue Into the Brain for Non-motor or Motor Symptoms in Patients With Parkinson's Disease Undergoing DBS Surgery
Parkinson's Disease
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: September 2026 · Data Methodology